SELLAS Life Sciences Group (SLS) Institutional Ownership → 25% of Americans Are In Grave Danger (From Banyan Hill Publishing) (Ad) Free SLS Stock Alerts $1.46 -0.01 (-0.68%) (As of 09:06 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$5.97MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.69K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC39,429$40K0.0%-34.2%0.068% 5/14/2024 Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024 Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024 Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024 Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% 9/12/2023 Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023 Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 1/18/2023 Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022 GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022 Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021 Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021 Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021 Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021 Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021 Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021 Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021 State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021 Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021 Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021 Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021 Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021 Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% 8/12/2021 Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021 Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, the following institutional investors and hedge funds held shares of SELLAS Life Sciences Group shares: Anson Funds Management LP ($4.88M), Highbridge Capital Management LLC ($2.58M), Armistice Capital LLC ($869K), Empery Asset Management LP ($623K), Opus Capital Group LLC ($203K), and Prosperity Financial Group Inc. ($47K), and Virtu Financial LLC ($40K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? The following institutional investors have purchased SELLAS Life Sciences Group stock in the last 24 months: Anson Funds Management LP ($4.83M), Highbridge Capital Management LLC ($1.81M), Armistice Capital LLC ($820K), Opus Capital Group LLC ($185.77K), and Prosperity Financial Group Inc. ($29.80K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 7,672,994 shares in the last 24 months. This purchase volume represents approximately $8.60M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($619.52K), and Virtu Financial LLC ($20.49K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 640,003 shares in the last 24 months. This volume of shares sold represents approximately $1.27M in transactions. Related Companies: Eledon Pharmaceuticals Major Shareholders Cellectar Biosciences Major Shareholders Q32 Bio Major Shareholders Nanobiotix Major Shareholders Atea Pharmaceuticals Major Shareholders Kamada Major Shareholders XOMA Major Shareholders ADC Therapeutics Major Shareholders CorMedix Major Shareholders Mersana Therapeutics Major Shareholders This page (NASDAQ:SLS) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.